These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 21490132

  • 1. Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells.
    Liu Y, Liu A, Li H, Li C, Lin J.
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1296-305. PubMed ID: 21490132
    [Abstract] [Full Text] [Related]

  • 2. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H, Guo Y, Li S, Han R, Ying J, Zhu H, Wang Y, Yin L, Han Y, Sun L, Wang Z, Lin Q, Bi X, Jiao Y, Jia H, Zhao J, Huang Z, Li Z, Zhou J, Song W, Meng K, Cai J.
    Oncotarget; 2015 Oct 13; 6(31):31927-43. PubMed ID: 26376676
    [Abstract] [Full Text] [Related]

  • 3. XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells.
    Liu Y, Liu A, Xu Z, Yu W, Wang H, Li C, Lin J.
    Apoptosis; 2011 May 13; 16(5):502-10. PubMed ID: 21311975
    [Abstract] [Full Text] [Related]

  • 4. Anticancer effects of celecoxib through inhibiton of STAT3 phosphorylation and AKT phosphorylation in nasopharyngeal carcinoma cell lines.
    Liu DB, Long GX, Mei Q, Wang JF, Hu GY, Gan L, Li WW, Sun W, Liu SF, Jiang JZ, Hu GQ.
    Pharmazie; 2014 May 13; 69(5):358-61. PubMed ID: 24855827
    [Abstract] [Full Text] [Related]

  • 5. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
    Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q, Cao P.
    Cancer Lett; 2013 Jan 28; 328(2):243-51. PubMed ID: 23032719
    [Abstract] [Full Text] [Related]

  • 6. IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma.
    Gu FM, Li QL, Gao Q, Jiang JH, Zhu K, Huang XY, Pan JF, Yan J, Hu JH, Wang Z, Dai Z, Fan J, Zhou J.
    Mol Cancer; 2011 Dec 15; 10():150. PubMed ID: 22171994
    [Abstract] [Full Text] [Related]

  • 7. Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3.
    Subramaniam A, Shanmugam MK, Ong TH, Li F, Perumal E, Chen L, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Hui KM, Sethi G.
    Br J Pharmacol; 2013 Oct 15; 170(4):807-21. PubMed ID: 23848338
    [Abstract] [Full Text] [Related]

  • 8. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
    Lee S, Lee M, Kim JB, Jo A, Cho EJ, Yu SJ, Lee JH, Yoon JH, Kim YJ.
    Biochem Biophys Res Commun; 2016 May 13; 473(4):1247-1254. PubMed ID: 27091428
    [Abstract] [Full Text] [Related]

  • 9. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
    Lai SC, Su YT, Chi CC, Kuo YC, Lee KF, Wu YC, Lan PC, Yang MH, Chang TS, Huang YH.
    J Exp Clin Cancer Res; 2019 Nov 26; 38(1):474. PubMed ID: 31771617
    [Abstract] [Full Text] [Related]

  • 10. Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells.
    Reed S, Li H, Li C, Lin J.
    Biochem Biophys Res Commun; 2011 Apr 15; 407(3):450-5. PubMed ID: 21397587
    [Abstract] [Full Text] [Related]

  • 11. IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells.
    Liu Y, Fuchs J, Li C, Lin J.
    Cell Cycle; 2010 Sep 01; 9(17):3423-7. PubMed ID: 20818158
    [Abstract] [Full Text] [Related]

  • 12. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y, Li W, Liu R, Guo Q, Li J, Bao Y, Zheng H, Jiang S, Hua B.
    Oncol Rep; 2017 Aug 01; 38(2):1224-1232. PubMed ID: 28677802
    [Abstract] [Full Text] [Related]

  • 13. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
    Ma H, Yan D, Wang Y, Shi W, Liu T, Zhao C, Huo S, Duan J, Tao J, Zhai M, Luo P, Guo J, Tian L, Mageta L, Jou D, Zhang C, Li C, Lin J, Lv J, Li S, Lin L.
    Cancer Sci; 2019 Mar 01; 110(3):950-961. PubMed ID: 30648776
    [Abstract] [Full Text] [Related]

  • 14. NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL-6/JAK2/STAT3 pathway activation.
    Kang JH, Li MJ, Luan PP, Jiang DK, Chen YW, Xu X, Yu Q, Xu YW, Su Q, Peng WH, Jian WX.
    Cell Biol Int; 2020 Oct 01; 44(10):2053-2064. PubMed ID: 32584509
    [Abstract] [Full Text] [Related]

  • 15. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
    Leng J, Han C, Demetris AJ, Michalopoulos GK, Wu T.
    Hepatology; 2003 Sep 01; 38(3):756-68. PubMed ID: 12939602
    [Abstract] [Full Text] [Related]

  • 16. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Sethi G.
    J Cell Physiol; 2012 May 01; 227(5):2184-95. PubMed ID: 21792937
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
    Moran DM, Mayes N, Koniaris LG, Cahill PA, McKillop IH.
    Liver Int; 2005 Apr 01; 25(2):445-57. PubMed ID: 15780071
    [Abstract] [Full Text] [Related]

  • 18. Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation.
    Liu DB, Hu GY, Long GX, Qiu H, Mei Q, Hu GQ.
    Acta Pharmacol Sin; 2012 May 01; 33(5):682-90. PubMed ID: 22504904
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells.
    Liu Y, Li PK, Li C, Lin J.
    J Biol Chem; 2010 Aug 27; 285(35):27429-27439. PubMed ID: 20562100
    [Abstract] [Full Text] [Related]

  • 20. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D.
    Mol Carcinog; 2009 Jan 27; 48(1):56-65. PubMed ID: 18506760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.